Selecta Biosciences

Selecta narrows focus to gout drug, freezing rest of pipeline
Fierce Biotech
Thu, 08/17/23 - 10:15 am
Selecta Biosciences
gout
SEL-212
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Fierce Biotech
Tue, 03/21/23 - 10:00 am
Sobi
Selecta Biosciences
gout
SEL-212
Horizon Therapeutics
Krystexxa
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot 'expeditiously'
Fierce Biotech
Thu, 03/10/22 - 10:27 pm
Selecta Biosciences
gene therapy
rare disease
methylmalonic acidemia
clinical trials
Takeda taps Selecta for $1.1B gene therapy research pact
Fierce Biotech
Mon, 10/4/21 - 10:43 am
Takeda
Selecta Biosciences
gene therapy
biobucks
Selecta lays off staff as R&D cash crunch looms
Fierce Biotech
Fri, 01/4/19 - 10:05 am
Selecta Biosciences
layoffs
R&D
SEL-212
gout
Polaris, Flagship, OrbiMed make it out with $70M IPO for Langer’s Selecta
Fierce Biotech
Thu, 06/23/16 - 08:24 pm
IPOs
SEL-212
Selecta Biosciences
Sanofi moving forward on Celiac disease immunotherapy development
BioPharma Dive
Thu, 05/14/15 - 11:04 am
Sanofi
celiac disease
R&D
Selecta Biosciences